Stocklytics Platform
Asset logo for symbol PMVP
PMV Pharmaceuticals
PMVP46
$1.63arrow_drop_up1.56%$0.02
Penny Stock
Asset logo for symbol PMVP
PMVP46

$1.63

arrow_drop_up1.56%

Performance History

Chart placeholder
Key Stats
Open$1.59
Prev. Close$1.60
EPS-1.01
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$86.41M
PE Ratio-
LOWHIGH
Day Range1.58
1.67
52 Week Range1.17
6.61
Ratios
Revenue-
EBITDA Margin %-
EPS-1.01

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About PMV Pharmaceuticals (PMVP)

PMV Pharmaceuticals, Inc. (PMVP) is a biopharmaceutical company focused on the discovery and development of precision medicine for cancer patients. The company is committed to targeting specific genetic alterations that drive tumor growth and proliferation, with the goal of developing therapies that have the potential to be highly effective and well-tolerated. PMVP's approach is rooted in the understanding that cancer is a complex disease, and that personalized treatment strategies are needed to overcome the heterogeneity of tumors. By identifying key genetic mutations and developing targeted therapies, PMVP aims to improve outcomes for cancer patients.
The stock price history of PMV Pharmaceuticals, Inc. (PMVP) reflects the company's growth and key milestones. Since its initial public offering (IPO) in [YEAR], the stock has experienced positive momentum, with steady increases in value. This reflects investor confidence in PMVP's innovative approach to cancer treatment and its potential to make a significant impact in the field. As PMVP continues to advance its pipeline and demonstrate progress in clinical development, the stock price is expected to reflect the company's achievements and future prospects.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. David H. Mack Ph.D.
Headquarters
Cranbury
Employees
62
Exchange
NASDAQ
add PMV Pharmaceuticals to watchlist

Keep an eye on PMV Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is PMV Pharmaceuticals's (PMVP) price per share?

The current price per share for PMV Pharmaceuticals (PMVP) is $1.63. The stock has seen a price change of $0.02 recently, indicating a 1.56% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for PMV Pharmaceuticals (PMVP)?

For PMV Pharmaceuticals (PMVP), the 52-week high is $6.61, which is 305.52% from the current price. The 52-week low is $1.18, the current price is 38.72% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is PMV Pharmaceuticals (PMVP) a growth stock?

PMV Pharmaceuticals (PMVP) has shown an average price growth of -2.94% over the past three years. It has received a score of 2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying PMV Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is PMV Pharmaceuticals (PMVP) stock price performance year to date (YTD)?

As of the latest data, PMV Pharmaceuticals (PMVP) has a year-to-date price change of -47.76%. Over the past month, the stock has experienced a price change of -1.81%. Over the last three months, the change has been 2.52%. Over the past six months, the figure is -18.91%.
help

Is PMV Pharmaceuticals (PMVP) a profitable company?

PMV Pharmaceuticals (PMVP) has a net income of -$68.96M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$80.13M. Furthermore, the EBITDA is -$77.12M.
help

What is the market capitalization of PMV Pharmaceuticals (PMVP)?

PMV Pharmaceuticals (PMVP) has a market capitalization of $86.42M. The average daily trading volume is 1.64, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level